Corline Biomedical AB (STO:CLBIO)

Sweden · Delayed Price · Currency is SEK

14.25

+0.05 (0.35%)

Sep 22, 2026, 1:48 PM CET

Corline Biomedical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	372	352	189	320	198	314
Market Cap Growth	2.39%	86.79%	-41.07%	61.60%	-36.85%	25.86%
Enterprise Value	344	347	181	303	169	271
Last Close Price	14.25	16.40	8.78	14.90	9.22	14.60

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	85.08	-
Forward PE	-	38.92	13.41	3.90	108.00	108.00
PS Ratio	30.06	46.07	19.30	9.02	8.41	44.43
PB Ratio	3.76	3.76	2.17	3.43	2.10	3.40
P/TBV Ratio	3.76	3.76	2.17	3.43	2.10	3.40
P/FCF Ratio	-	-	-	424.69	-	-
P/OCF Ratio	-	-	-	361.41	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	27.80	45.31	18.55	8.54	7.19	38.35
EV/EBITDA Ratio	-	-	-	-	71.03	-
EV/EBIT Ratio	-	-	-	-	72.74	-
EV/FCF Ratio	-	-	-	402.14	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.05	0.04	0.02	-	-	-
Net Debt / Equity Ratio	-0.28	-0.18	-0.18	-0.18	-0.28	-0.45
Net Debt / EBITDA Ratio	2.28	1.14	1.16	8.09	-10.99	6.05
Net Debt / FCF Ratio	1.89	0.94	1.81	-22.56	3.97	8.37
Asset Turnover	0.12	0.08	0.10	0.35	0.23	0.09
Quick Ratio	6.12	4.74	2.59	3.28	4.82	4.71
Current Ratio	6.49	4.98	2.68	3.51	5.00	4.75
Return on Equity (ROE)	-13.72%	-16.29%	-25.74%	-1.93%	2.49%	-9.60%
Return on Assets (ROA)	-7.74%	-9.56%	-8.72%	-1.36%	1.43%	-5.40%
Return on Capital Employed (ROCE)	-11.50%	-15.80%	-15.60%	-2.40%	2.50%	-7.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-3.31%	-4.17%	-12.29%	-0.56%	1.18%	-2.21%
FCF Yield	-3.98%	-5.03%	-4.58%	0.24%	-3.33%	-1.59%
Buyback Yield / Dilution	-9.08%	-13.40%	-1.49%	2.19%	-7.50%	-22.58%